98 related articles for article (PubMed ID: 12169768)
1. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus.
Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR
Neuroendocrinology; 2002 Aug; 76(2):70-8. PubMed ID: 12169768
[TBL] [Abstract][Full Text] [Related]
2. Independent and overlapping effects of corticosterone and testosterone on corticotropin-releasing hormone and arginine vasopressin mRNA expression in the paraventricular nucleus of the hypothalamus and stress-induced adrenocorticotropic hormone release.
Viau V; Chu A; Soriano L; Dallman MF
J Neurosci; 1999 Aug; 19(15):6684-93. PubMed ID: 10414997
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene.
Agarwal A; Halvorson LM; Legradi G
Brain Res Mol Brain Res; 2005 Jul; 138(1):45-57. PubMed ID: 15882914
[TBL] [Abstract][Full Text] [Related]
4. Tuberoinfundibular peptide of 39 residues modulates the mouse hypothalamic-pituitary-adrenal axis via paraventricular glutamatergic neurons.
Dimitrov E; Usdin TB
J Comp Neurol; 2010 Nov; 518(21):4375-94. PubMed ID: 20853513
[TBL] [Abstract][Full Text] [Related]
5. Electroacupuncture in the treatment of IBS in rats: investigation of the mechanisms of CRH
Gao F; Yuan WH; Wu SB; Wang ZB; Zhu GQ; Zhou MQ
J Neurophysiol; 2023 Aug; 130(2):380-391. PubMed ID: 37435647
[TBL] [Abstract][Full Text] [Related]
6. Impact and Role of Hypothalamic Corticotropin Releasing Hormone Neurons in Withdrawal from Chronic Alcohol Consumption in Female and Male Mice.
Neira S; Lee S; Hassanein LA; Sides T; D'Ambrosio SL; Boyt KM; Bains JS; Kash TL
J Neurosci; 2023 Nov; 43(45):7657-7667. PubMed ID: 37833068
[TBL] [Abstract][Full Text] [Related]
7. Paraventricular nucleus corticotrophin releasing hormone contributes to sympathoexcitation via interaction with neurotransmitters in heart failure.
Kang YM; Zhang AQ; Zhao XF; Cardinale JP; Elks C; Cao XM; Zhang ZW; Francis J
Basic Res Cardiol; 2011 May; 106(3):473-83. PubMed ID: 21287352
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice.
Pirník Z; Kořínková L; Osacká J; Železná B; Kuneš J; Maletínská L
Physiol Res; 2021 Aug; 70(4):579-590. PubMed ID: 34062082
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis.
Smith EM
Brain Behav Immun; 2008 Jan; 22(1):3-14. PubMed ID: 17900859
[TBL] [Abstract][Full Text] [Related]
10. Serotonin mediated changes in corticotropin releasing factor mRNA expression and feeding behavior isolated to the hypothalamic paraventricular nuclei.
Boisvert JP; Boschuetz TJ; Resch JM; Mueller CR; Choi S
Neurosci Lett; 2011 Jul; 498(3):213-7. PubMed ID: 21600959
[TBL] [Abstract][Full Text] [Related]
11. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors.
Kinzig KP; D'Alessio DA; Herman JP; Sakai RR; Vahl TP; Figueiredo HF; Murphy EK; Seeley RJ
J Neurosci; 2003 Jul; 23(15):6163-70. PubMed ID: 12867498
[TBL] [Abstract][Full Text] [Related]
12. A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH.
Macova M; Pavel J; Saavedra JM
Brain Res; 2009 Jan; 1250():130-40. PubMed ID: 19038235
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture Alleviates Anxiety and 22-kHz Ultrasonic Vocalizations in Rats Subjected to Repeated Alcohol Administration by Modulating the Brain-Derived Neurotrophic Factor/Corticotropin-Releasing Hormone Signaling Pathway.
Seo SY; Bang SK; Kang SY; Cho SJ; Choi KH; Ryu YH
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919862
[TBL] [Abstract][Full Text] [Related]
14. Optogenetic recruitment of hypothalamic corticotrophin-releasing-hormone (CRH) neurons reduces motivational drive.
Mitchell CS; Campbell EJ; Fisher SD; Stanton LM; Burton NJ; Pearl AJ; McNally GP; Bains JS; Füzesi T; Graham BA; Manning EE; Dayas CV
Transl Psychiatry; 2024 Jan; 14(1):8. PubMed ID: 38191479
[TBL] [Abstract][Full Text] [Related]
15. Larger hypothalamic subfield volumes in patients with chronic insomnia disorder and relationships to levels of corticotropin-releasing hormone.
Luo Y; Yu L; Zhang P; Lin W; Xu H; Dou Z; Zhao G; Peng W; Zeng F; Yu S
J Affect Disord; 2024 Apr; 351():870-877. PubMed ID: 38341156
[TBL] [Abstract][Full Text] [Related]
16. Fingerprints of CNS drug effects: a plasma neuroendocrine reflection of D
van den Brink WJ; van den Berg DJ; Bonsel FEM; Hartman R; Wong YC; van der Graaf PH; de Lange ECM
Br J Pharmacol; 2018 Oct; 175(19):3832-3843. PubMed ID: 30051461
[TBL] [Abstract][Full Text] [Related]
17. An analogue of the Prolactin Releasing Peptide reduces obesity and promotes adult neurogenesis.
Jörgensen SK; Karnošová A; Mazzaferro S; Rowley O; Chen HC; Robbins SJ; Christofides S; Merkle FT; Maletínská L; Petrik D
EMBO Rep; 2024 Jan; 25(1):351-377. PubMed ID: 38177913
[TBL] [Abstract][Full Text] [Related]
18. The role of neuropeptides in suicidal behavior: a systematic review.
Serafini G; Pompili M; Lindqvist D; Dwivedi Y; Girardi P
Biomed Res Int; 2013; 2013():687575. PubMed ID: 23986909
[TBL] [Abstract][Full Text] [Related]
19. Smaller hypothalamic subregion with paraventricular nucleus in patients with panic disorder.
Sasaki R; Asami T; Takaishi M; Nakamura R; Roppongi T; Yoshimi A; Hishimoto A
Brain Imaging Behav; 2024 Feb; ():. PubMed ID: 38376715
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
